310 related articles for article (PubMed ID: 18552237)
41. Effect of the dialysate effluent from CAPD patients on peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Patrikarea A; Martis L; Oreopoulos DG
Adv Perit Dial; 1994; 10():230-4. PubMed ID: 7999835
[TBL] [Abstract][Full Text] [Related]
42. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
Fusshoeller A; Plail M; Grabensee B; Plum J
Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
[TBL] [Abstract][Full Text] [Related]
43. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
[TBL] [Abstract][Full Text] [Related]
44. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
[TBL] [Abstract][Full Text] [Related]
45. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
Williams JD; Topley N; Craig KJ; Mackenzie RK; Pischetsrieder M; Lage C; Passlick-Deetjen J;
Kidney Int; 2004 Jul; 66(1):408-18. PubMed ID: 15200450
[TBL] [Abstract][Full Text] [Related]
46. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
[TBL] [Abstract][Full Text] [Related]
47. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
[TBL] [Abstract][Full Text] [Related]
48. Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: prospective cross-over study with a three-compartment bag.
Cappelli G; Bandiani G; Cancarini GC; Feriani M; Dell'Aquila R; Saffioti S; Spisni C; Stingone A; Orazi E; Ballocchi S; Renaux JL
Adv Perit Dial; 1999; 15():238-42. PubMed ID: 10682110
[TBL] [Abstract][Full Text] [Related]
49. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
50. Influence of pH-neutral peritoneal dialysis solution.
Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590
[TBL] [Abstract][Full Text] [Related]
51. The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.
Cho KH; Do JY; Park JW; Yoon KW; Kim YL
Perit Dial Int; 2013; 33(4):382-90. PubMed ID: 23284074
[TBL] [Abstract][Full Text] [Related]
52. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
[TBL] [Abstract][Full Text] [Related]
53. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
54. IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway.
Xiao J; Gong Y; Chen Y; Yu D; Wang X; Zhang X; Dou Y; Liu D; Cheng G; Lu S; Yuan W; Li Y; Zhao Z
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F310-F318. PubMed ID: 28490530
[TBL] [Abstract][Full Text] [Related]
55. Effluent markers related to epithelial mesenchymal transition with adjusted values for effluent cancer antigen 125 in peritoneal dialysis patients.
Mizuiri S; Hemmi H; Arita M; Tai R; Hattori Y; Muto A; Suzuki Y; Ohashi Y; Sakai K; Aikawa A
Int J Nephrol; 2011; 2011():261040. PubMed ID: 21755056
[TBL] [Abstract][Full Text] [Related]
56. The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells.
Lee SH; Kang HY; Kim KS; Nam BY; Paeng J; Kim S; Li JJ; Park JT; Kim DK; Han SH; Yoo TH; Kang SW
Lab Invest; 2012 Dec; 92(12):1698-711. PubMed ID: 23007133
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
[TBL] [Abstract][Full Text] [Related]
58. A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.
Lai KN; Lam MF; Leung JC; Chan LY; Lam CW; Chan IH; Chan HW; Li CS; Wong SS; Ho YW; Cheuk A; Tong MK; Tang SC
Perit Dial Int; 2012; 32(3):280-91. PubMed ID: 22045098
[TBL] [Abstract][Full Text] [Related]
59. Dialysate CA125 in stable CAPD patients: no relation with transport parameters.
Pannekeet MM; Koomen GC; Struijk DG; Krediet RT
Clin Nephrol; 1995 Oct; 44(4):248-54. PubMed ID: 8575125
[TBL] [Abstract][Full Text] [Related]
60. Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.
Witowski J; Bender TO; Wisniewska-Elnur J; Ksiazek K; Passlick-Deetjen J; Breborowicz A; Jörres A
Perit Dial Int; 2003; 23(4):381-90. PubMed ID: 12968847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]